FDA Inspection 1025621 — Reproductive Genetic Innovations LLC
The FDA completed an inspection of Reproductive Genetic Innovations LLC on September 11, 2017 in Northbrook, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 11, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Northbrook, IL (United States)